Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

Busse, W. W., Corren, J., Lanier, B. Q., McAlary, M., FowlerTaylor, A., Cioppa, G. D., van As, A., & Gupta, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.117880 · Cited by 1,309 · see citing works

Treatment of Allergic Asthma with Monoclonal Anti-IgE Antibody

Milgrom, H., Fick, R. B., Su, J. Q., Reimann, J. D., Bush, R. K., Watrous, M. L., & Metzger, W. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412603 · Cited by 703 · see citing works

The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation

Holgate, S. T., Casale, T. B., Wenzel, S. E., Bousquet, J., Deniz, Y. M., & Reisner, C. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.11.053 · Cited by 466 · see citing works

Effect of Omalizumab on Symptoms of Seasonal Allergic Rhinitis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Casale, T. B. (2001) · JAMA · doi:10.1001/jama.286.23.2956 · Cited by 377 · see citing works

Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis☆☆☆★★★

Casale, T. B., Bernstein, I. L., Busse, W. W., LaForce, C., Tinkelman, D. G., Stoltz, R. R., Dockhorn, R. J., Reimann, J. D., Su, J. Q., & Fick, R. B. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70202-1 · Cited by 326 · see citing works

Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils

Lin, H. C., Boesel, K. M., Griffith, D. T., Prussin, C., Foster, B. A., Romero, F. A., Townley, R. G., & Casale, T. B. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.11.044 · Cited by 267 · see citing works

Anti-IgE for chronic asthma in adults and children

Walker, S. M., Monteil, M., Phelan, K. J., Lasserson, T. J., & Walters, E. H. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003559.pub3 · Cited by 239 · see citing works

Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo.

Saini, S. S., MacGlashan, D. W., Sterbinsky, S. A., Togias, A. G., Adelman, D. C., Lichtenstein, L. M., & Bochner, B. S. (1999) · PubMed · Cited by 207 · see citing works

Down-Regulation of Human Basophil IgE and FCεRIα Surface Densities and Mediator Release by Anti-IgE-Infusions Is Reversible In Vitro and In Vivo

Saini, S. S., MacGlashan, D. W., Sterbinsky, S. A., Togias, A. G., Adelman, D. C., Lichtenstein, L. M., & Bochner, B. S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5624 · Cited by 181 · see citing works

Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma

Hochhaus, G., Brookman, L. J., Fox, H., Johnson, C. L., Matthews, J. G., Ren, S., & Deniz, Y. M. (2003) · Current Medical Research and Opinion · doi:10.1185/030079903125002171 · Cited by 180 · see citing works

The relationship between serum IgE and surface levels of FcϵR on human leukocytes in various diseases: Correlation of expression with FcϵRI on basophils but not on monocytes or eosinophils

Saini, S. S., Klion, A. D., Holland, S. M., Hamilton, R. G., Bochner, B. S., & MacGlashan, D. W. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.108431 · Cited by 129 · see citing works

Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge

Ong, Y. E., Menzies-Gow, A. N., Barkans, J. R., Benyahia, F., Ou, T.-T., Sun, Y., & Kay, A. B. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.05.035 · Cited by 97 · see citing works

Comparative pharmacology of H1 antihistamines: clinical relevance

Simons, F. E. R. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01436-5 · Cited by 94 · see citing works

Omalizumab: a monoclonal anti-IgE antibody.

Belliveau, P. (2005) · PubMed · Cited by 84 · see citing works

Anti-IgE for chronic asthma in adults and children (Review)

Walker, S. L., Monteil, M., Phelan, K. J., Lasserson, T., & Walters, E. H. (2004) · eCite Digital Repository (University of Tasmania) · Cited by 80 · see citing works

Serum IgE Level Drives Basophil and Mast Cell IgE Receptor Display

MacGlashan, D. W., Bochner, B. S., Adelman, D. C., Jardieu, P. M., Togias, A. G., & Lichtenstein, L. M. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000237504 · Cited by 62 · see citing works

Anti-IgE antibodies for the treatment of asthma

Buhl, R. (2004) · Current Opinion in Internal Medicine · doi:10.1097/01.mcp.0000147860.83639.30 · Cited by 52 · see citing works

The importance of IgE antibody levels in anti‐IgE treatment

Johansson, S. G. O., Öman, H., Nopp, A., & Pettersson, S. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01172.x · Cited by 27 · see citing works

Omalizumab and the treatment of allergic rhinitis

Kaliner, M. (2004) · Current Allergy and Asthma Reports · doi:10.1007/s11882-004-0032-2 · Cited by 23 · see citing works

IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

Ansotegui, I. J., Melioli, G., Canonica, G. W., Caraballo, L. R., Villa, E., Ebisawa, M., Passalacqua, G., Savi, E., Ebo, D. G., Gómez, R. M., et al. (2020) · World Allergy Organization Journal · doi:10.1016/j.waojou.2019.100080 · Cited by 584 · see citing works

International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis

Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557 · see citing works

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

Wise, S. K., Damask, C. C., Roland, L. T., Ebert, C. S., Levy, J. M., Lin, S. Y., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E. M., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 554 · see citing works

Omalizumab facilitates rapid oral desensitization for peanut allergy

MacGinnitie, A. J., Rachid, R. A., Gragg, H., Little, S. V., Lakin, P. R., Cianferoni, A., Heimall, J. R., Makhija, M., Robison, R. G., Chinthrajah, R. S., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.010 · Cited by 325 · see citing works

Conducting an Oral Food Challenge: An Update to the 2009 Adverse Reactions to Foods Committee Work Group Report

Bird, J. A., Leonard, S. A., Groetch, M., Assa’ad, A., Cianferoni, A., Clark, A., Crain, M. G., Fausnight, T. B., Fleischer, D. M., Green, T. D., et al. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.09.029 · Cited by 244 · see citing works

Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement

Orengo, J. M., Radin, A. R., Kamat, V., Badithe, A., Ben, L. H., Bennett, B. L., Zhong, S., Birchard, D., Limnander, A., Rafique, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03636-8 · Cited by 237 · see citing works

Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course – a randomized, placebo‐controlled and double blind pilot study

Heil, P. M., Maurer, D., Klein, B., Hultsch, T., & Stingl, G. (2010) · JDDG: Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2010.07497.x · Cited by 197 · see citing works

Endotype-driven treatment in chronic upper airway diseases

Greve, G. D., Hellings, P. W., Fokkens, W. J., Pugin, B., Steelant, B., & Seys, S. (2017) · Clinical and Translational Allergy · doi:10.1186/s13601-017-0157-8 · Cited by 175 · see citing works

Omalizumab therapy for bullous pemphigoid

Yu, K. K., Crew, A. B., Messingham, K. N., Fairley, J. A., & Woodley, D. T. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.04.053 · Cited by 174 · see citing works

Advances in mechanisms of asthma, allergy, and immunology in 2010

Broide, D. H., Finkelman, F. D., Bochner, B. S., & Rothenberg, M. E. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.027 · Cited by 172 · see citing works

Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab

Fairley, J. A., Baum, C. L., Brandt, D. S., & Messingham, K. N. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.11.035 · Cited by 154 · see citing works

Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness

Pelaia, C., Calabrese, C., Terracciano, R., Blasio, F. D., Vatrella, A., & Pelaia, G. (2018) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466618810192 · Cited by 147 · see citing works

Pathophysiology of asthma: What has our current understanding taught us about new therapeutic approaches?

Holgate, S. T. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.06.052 · Cited by 136 · see citing works

House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies

Calderón, M. A., Kleine‐Tebbe, J., Linneberg, A. R., Frederic de, B. L. A. Y., de Rojas, D. H. F., Virchow, J. C., Jr., & Demoly, P. M. (2015) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2015.06.019 · Cited by 123 · see citing works

Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions

Oppenheimer, J. J., Hoyte, F. C. L., Phipatanakul, W., Silver, J. N., Howarth, P. H., & Lugogo, N. L. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.02.021 · Cited by 119 · see citing works

AAAAI–EAACI PRACTALL : Standardizing oral food challenges—2024 Update

Sampson, H. A., Arasi, S., Bahnson, H. T., Ballmer-Weber, B. K., Beyer, K., Bindslev‐Jensen, C., Bird, J. A., Blümchen, K., Davis, C. M., Ebisawa, M., et al. (2024) · Pediatric Allergy and Immunology · doi:10.1111/pai.14276 · Cited by 96 · see citing works

Anti-IgE for the Treatment of Allergic Rhinitis – and Eventually Nasal Polyps?

Verbruggen, K., Cauwenberge, P. V., & Bachert, C. (2008) · International Archives of Allergy and Immunology · doi:10.1159/000155739 · Cited by 77 · see citing works

Update on optimal use of omalizumab in management of asthma

Pelaia, G. (2011) · Journal of Asthma and Allergy · doi:10.2147/jaa.s14520 · Cited by 70 · see citing works

Increased IgE levels are linked to faster relapse in patients with omalizumab-discontinued chronic spontaneous urticaria

Ertaş, R., Özyurt, K., Özlü, E., Ulaş, Y., Avcı, A., Atasoy, M., Hawro, T., & Maurer, M. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.08.007 · Cited by 67 · see citing works

The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid

Messingham, K. N., Crowe, T. P., & Fairley, J. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02331 · Cited by 66 · see citing works

Oral Immunotherapy and Anti-IgE Antibody-Adjunctive Treatment for Food Allergy

Nadeau, K. C., Kohli, A., Iyengar, S. R., DeKruyff, R. H., & Umetsu, D. T. (2012) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2011.11.004 · Cited by 64 · see citing works

Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease

Gomez, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00175 · Cited by 61 · see citing works

Anti-IgE – emerging opportunities for Omalizumab

Babu, K. S., Polosa, R., & Morjaria, J. B. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.782391 · Cited by 55 · see citing works

A novel IgE-neutralizing antibody for the treatment of severe uncontrolled asthma

Cohen, E. S., Dobson, C., Käck, H., Wang, B., Sims, D. A., Lloyd, C., England, E., Rees, D. G., Guo, H., Karagiannis, S. N., et al. (2014) · mAbs · doi:10.4161/mabs.28394 · Cited by 54 · see citing works

Peritoneal injection of fucoidan suppresses the increase of plasma IgE induced by OVA-sensitization

Yanase, Y., Hiragun, T., Uchida, K., Ishii, K., Oomizu, S., Suzuki, H., Mihara, S., Iwamoto, K., Matsuo, H., Onishi, N., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.031 · Cited by 51 · see citing works

Targeted therapy in severe asthma today: focus on immunoglobulin E

Pelaia, G., Canonica, G. W., Matucci, A., Paolini, R., Triggiani, M., & Paggiaro, P. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s130743 · Cited by 49 · see citing works

Immunological mechanisms for desensitization and tolerance in food allergy

Rachid, R. A., & Umetsu, D. T. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0333-9 · Cited by 47 · see citing works

Novel Approaches in the Inhibition of IgE-Induced Mast Cell Reactivity in Food Allergy

Tontini, C., & Bulfone‐Paus, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.613461 · Cited by 46 · see citing works

Immunoglobulin E and bullous pemphigoid

Cozzani, E., Gasparini, G., Zenzo, G. D., & Parodi, A. (2018) · European Journal of Dermatology · doi:10.1684/ejd.2018.3366 · Cited by 45 · see citing works

Advances in mechanisms of asthma, allergy, and immunology in 2008

Boyce, J. A., Broide, D. H., Matsumoto, K., & Bochner, B. S. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.01.041 · Cited by 44 · see citing works

Loss of asthma control after cessation of omalizumab treatment: real life data

Kuprys-Lipinska, I. R., & Kuna, P. (2014) · Advances in Dermatology and Allergology · doi:10.5114/pdia.2014.40553 · Cited by 43 · see citing works

Treatment of food allergy

Sindher, S., Hillier, C., Anderson, B., Long, A. J., & Chinthrajah, R. S. (2023) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2023.04.023 · Cited by 39 · see citing works

IgE autoantibodies in bullous pemphigoid: Supporting role, or leading player?

Ujiie, H. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.03.002 · Cited by 36 · see citing works

Maintenance of Remission With Low-Dose Omalizumab in Long-Lasting, Refractory Chronic Urticaria

Romano, C. P., Sellitto, A., Fanis, U. D., Esposito, G., Arbo, P., Giunta, R. E., & Lucivero, G. (2010) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2009.11.017 · Cited by 36 · see citing works

Immunopharmacological modulation of mast cells

Borriello, F., Granata, F., Varricchi, G., Genovese, A., Triggiani, M., & Marone, G. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.07.002 · Cited by 35 · see citing works

Anti-IgE treatment in allergic rhinitis

Muluk, N. B., Bafaqeeh, S. A., & Cingi, C. (2019) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2019.109674 · Cited by 34 · see citing works

A step‐down protocol for omalizumab treatment in oral corticosteroid‐dependent allergic asthma patients

Domingo, C., Pomares, X., Navarro, A., Amengual, M. J., Montón, C., Sogo, A., & Mirapeix, R. M. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13453 · Cited by 31 · see citing works

A review of omalizumab for the management of severe asthma

Shih-Lung, C., & Lin, C. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s112208 · Cited by 27 · see citing works

Anti-IgE therapy for allergic bronchopulmonary aspergillosis

Homma, T., Kurokawa, M., Matsukura, S., Yamaguchi, M., & Adachi, M. (2013) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2013.10.003 · Cited by 27 · see citing works

Hypersensitivity and adverse reactions to biologics for asthma and allergic diseases

Jackson, K., & Bahna, S. L. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1724089 · Cited by 26 · see citing works

The high-affinity immunoglobulin E receptor as pharmacological target

Blank, U., Charles, N., & Benhamou, M. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.070 · Cited by 24 · see citing works

Presence of positive skin prick tests to inhalant allergens and markers of T2 inflammation in subjects with chronic spontaneous urticaria (CSU): a systematic literature review

Wong, M. M., & Keith, P. K. (2020) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-020-00461-x · Cited by 24 · see citing works

Monitoring Allergic Patients on Omalizumab with Free and Total Serum IgE Measurements

Hamilton, R. G. (2016) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2015.12.002 · Cited by 22 · see citing works

IgE and IgG4 Repertoire in Asymptomatic HDM-Sensitized and HDM-Induced Allergic Rhinitis Patients

Xu, Q., Jiang, Q., Yang, L., Li, W., Huang, N., Yang, Y., Ma, D., Zhang, S., Wang, Y., & Zhu, R. (2021) · International Archives of Allergy and Immunology · doi:10.1159/000517824 · Cited by 20 · see citing works

Review: Omalizumab in the treatment of severe asthma: efficacy and current problems

Pelaia, G., Renda, T., Romeo, P., Busceti, M. T., & Maselli, R. (2008) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465808100431 · Cited by 18 · see citing works

Allergy Testing

Tourlas, K., & Burman, D. (2016) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2016.04.001 · Cited by 15 · see citing works

Variability of Total and Free IgE Levels and IgE Receptor Expression in Allergic Subjects in and Out of Pollen Season

Carlsson, M., Thorell, L., Sjölander, A., & Larsson‐Faria, S. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12270 · Cited by 14 · see citing works

Anti-Immunoglobulin E Therapy

Segal, M., Stokes, J. R., & Casale, T. B. (2008) · World Allergy Organization Journal · doi:10.1097/wox.0b013e318187a310 · Cited by 14 · see citing works

Severe Anaphylactic Shock Due to Ethylene Oxide in a Patient with Myelomeningocele

Listyo, A., Scherer, K., Bandschapp, O., Erb, T. O., Hasler, C.-C., & Bircher, A. J. (2014) · A & A Case Reports · doi:10.1097/acc.0b013e3182a08ff1 · Cited by 13 · see citing works

Omalizumab in the treatment of asthma

Tan, R. A., & Corren, J. (2011) · Expert Review of Respiratory Medicine · doi:10.1586/ers.11.73 · Cited by 12 · see citing works

Quantitation of serum IgE by using chimeras of human IgE receptor and avian immunoglobulin domains

Braren, I., Greunke, K., Pilette, C., Mempel, M., Grunwald, T., Bredehorst, R., Ring, J., Spillner, E., & Ollert, M. W. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.12.013 · Cited by 12 · see citing works

Anti-IgE in the treatment of allergic disorders in pediatrics

Fried, A. J., & Oettgen, H. C. (2010) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283404201 · Cited by 10 · see citing works

Omalizumab Implementation in Practice: Lessons Learned From the OUtMATCH Study

Vickery, B. P., Bird, J. A., Chinthrajah, R. S., Jones, S. M., Keet, C. A., Kim, E., Leung, D. Y. M., Shreffler, W. G., Sicherer, S. H., Sindher, S., et al. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.08.056 · Cited by 10 · see citing works

Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech Anti-IgE Registry

Vaník, P., Novosad, J., Kirchnerová, O., Krčmová, I., Teřl, M., & Czech Anti-IgE Registry collaborators (2020) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-020-00479-1 · Cited by 10 · see citing works

Advances in upper airway diseases and allergen immunotherapy

Sabin, B. R., Saltoun, C. A., & Avila, P. C. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.049 · Cited by 10 · see citing works

Indian Guidelines for Diagnosis of Respiratory Allergy

Kumar, R., Behera, D., Singh, A. B., Gaur, S., Agarwal, M. K., Prasad, R., Menon, B., Goel, N., Mrigpuri, P., Spalgais, S., et al. (2023) · Indian Journal of Allergy Asthma and Immunology · doi:10.4103/0972-6691.367373 · Cited by 8 · see citing works

Novel Biological Therapies in Severe Asthma: Targeting the Right Trait

Varricchi, G., Marone, G., Spadaro, G., Russo, M., Granata, F., Genovese, A., & Marone, G. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867325666180110094542 · Cited by 7 · see citing works

Small, Prospective, Observational, Pilot Study in Patients with Severe Asthma after Discontinuation of Omalizumab Treatment

Krčmová, I., Novosad, J., Мала, Э., & Krejsek, J. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.09.004 · Cited by 6 · see citing works

Multiple Allergen Simultaneous Test-Immunoblot Assay for Immunoglobulin E Detection in Patients with Isolated Allergic Conjunctivitis

Han, J. Y., Lee, H., Chung, J. L., Kim, Y. J., Kim, J. Y., & Tchah, H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10050960 · Cited by 7 · see citing works

Omalizumab for severe atopic dermatitis in 4- to 19-year-olds: the ADAPT RCT

Chan, S., Cro, S., Cornelius, V. R., Jahan, R., Radulović, S., & Lack, G. (2022) · Efficacy and Mechanism Evaluation · doi:10.3310/wcxn5739 · Cited by 5 · see citing works

Successful Withdrawal of Omalizumab in a Patient with Severe Asthma: Free IgE as a Possible Biomonitor

Domingo, C., Pomares, X., Amengual, M. J., & Ollert, M. W. (2014) · European Journal of Inflammation · doi:10.1177/1721727x1401200217 · Cited by 5 · see citing works

In Vivo Testing for Immunoglobulin E-Mediated Sensitivity

Nelson, H. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29875-9.00019-7 · Cited by 4 · see citing works

Biologic Therapies in Severe Asthma: Current Landscape, Clinical Evidence, and Future Directions

Okuducu, Y. K., & Kinane, T. B. (2025) · Current Pediatrics Reports · doi:10.1007/s40124-025-00373-7 · Cited by 3 · see citing works

Role of anti-IgE in immediate drug allergy

Li, L., & Blumenthal, K. G. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.09.021 · Cited by 3 · see citing works

Basics of Skin Testing and Drug Challenges

Park, M. A., & May, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48551-7.00007-9 · Cited by 2 · see citing works

Persistent severe asthma and aging: step-up therapy with omalizumab to improve control

Greenberger, P. A. (2010) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2010.09.013 · Cited by 2 · see citing works

Machine Learning-Based Prediction of Free Ige Concentration in Allergic Rhinitis Patients Treated with Allergen Immunotherapy and Omalizumab

Olanrewaju, K. B., & Djampou, L. M. E. N. (2023) · Archives of Microbiology & Immunology · doi:10.26502/ami.936500130 · Cited by 1 · see citing works

In Vivo Testing for Immunoglobulin E-Mediated Sensitivity

Nelson, H. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0271-2.00023-7 · Cited by 1 · see citing works

Epicutaneous and intradermal skin testing

Seth, D., & Poowuttikul, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95061-9.00009-6 · Cited by 1 · see citing works

Anti-IgE Therapy

Pelaia, G., Vatrella, A., & Maselli, R. (2016) · Springer eBooks · doi:10.1007/978-3-319-46007-9_4 · Cited by 1 · see citing works

Skin tests in the diagnosis of food allergy

Titova, N. (2021) · Immunopathology Allergology Infectology · doi:10.14427/jipai.2021.4.6 · Cited by 1 · see citing works

Bronchodilators

Emala, C. W. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781933.048

Anti IgE Therapy in Chronic Urticaria

Ertaş, R. (2017) · InTech eBooks · doi:10.5772/68015

Allergy Skin Testing

Wang, V. Y., Jiang, F., Kallepalli, A., & Yusin, J. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-58726-4_33-1

Skin Testing and Specific-IgE Following IVIG or Omalizumab

Ledford, D. K. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.01.046

Оценка эффективности и безопасности омализумаба в комплексной терапии больных с тяжелой неконтролируемой атопической бронхиальной астмой в течение 12 месяцев наблюдения

Сучкова, Ю. Б., Osipova, G. L., Чучалин, А. Г., & Пашкова, Т. Л. (2009) · PULMONOLOGIYA · doi:10.18093/0869-0189-2009-3-75-80

Allergy Skin Testing

Wang, V. Y., Jiang, F., Kallepalli, A., & Yusin, J. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-58726-4_33-2

Allergy Skin Testing

Wang, V. Y., Jiang, F., Kallepalli, A., & Yusin, J. S. (2019) · Springer eBooks · doi:10.1007/978-3-030-05147-1_33

Asthma

CICCOLELLA, D. E., & D’Alonzo, G. E. (2013) · CRC Press eBooks · doi:10.1201/b13781-65

Management of food-induced allergic reactions: General

Galvan‐Blasco, P., & Cardona, V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96018-2.00123-1

Allergy Skin Testing

Vaughn, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-93455-1_13

Biologics and Novel Therapeutics in Food Allergy

Anderson, B., Pascal, C., Butler, M., Chin, A. R., Long, A. J., Sindher, S., Anagnostou, A., Arasi, S., Bégin, P., Ciaccio, C. E., et al. (2026) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2026.01.044

Important Considerations in the Interpretation of Diagnostic Testing in Allergy

Rowland, A., Tayidi, I. T., & Lee, G. B. (2026) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2026.06.013

The Effect of Discontinuing Omalizumab Therapy on Free IgE Concentration

Lowe, P. J., Jaffe, J., Martín, C., Brookman, L. J., & Fox, H. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.11.040 · Cited by 2 · see citing works

Serum free IgE guided dose reduction of omalizumab: a case report

Gon, Y., Ito, R., Maruoka, S., Mizumura, K., Kozu, Y., Hiranuma, H., Iida, Y., Shikano, S., & Hashimoto, S. (2017) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-017-0211-z · Cited by 1 · see citing works

Asthma symptom re-emergence after omalizumab withdrawal correlates well with increasing IgE and decreasing pharmacokinetic concentrations

Slavin, R. G., Ferioli, C., Tannenbaum, S. J., Martin, C., Blogg, M., & Lowe, P. J. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.09.050 · Cited by 136 · see citing works

Immunoglobulin E monitoring and reduction of omalizumab therapy in children and adolescents

Steiß, J.-O., Schmidt, A., Naehrlich, L., Zimmer, K., & Rudloff, S. (2012) · Allergy and Asthma Proceedings · doi:10.2500/aap.2012.33.3500 · Cited by 13 · see citing works

Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis

Corren, J., Díaz-Sánchez, D., Saxon, A., Deniz, Y. M., Reimann, J. D., Sinclair, D., Davancaze, T., & Adelman, D. C. (2004) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61495-0 · Cited by 29 · see citing works